18. Grover R, Zaccardelli D, Colice G, Guntupalli K, Watson D, Vincent JL (1999) An open-label
dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydro-
chloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock
Study Group. Crit Care Med 27:913–922
Bạn đang xem 18. - UPDATE IN INTENSIVE CARE AND EMERGENCY MEDICINE PART 3 POTX
